Development of health-based exposure limits for radiofrequency radiation from wireless devices using a benchmark dose approach

Table 3 BMDS modeling of cancer incidence in male rats using the MS Combo model. Neoplasm incidence data analyzed here included all exposure groups

Exposure condition and tumor type	BMD₅	BMDL₅	BMD₁₀	BMDL₁₀
CDMA, heart schwannoma	4.29	2.71	8.82^a	5.40
CDMA, pituitary gland adenoma	Could not be modeled
CDMA, liver adenoma	Could not be modeled
CDMA, combined heart schwannoma, liver adenoma, and pituitary gland adenoma	Could not be modeled
GSM, heart schwannoma	5.94	3.49	11.82^a	6.20
GSM, brain malignant glioma	9.00^a	3.60	Could not be modeled
GSM, brain meninges neoplasm (benign and malignant)	11.31^a	3.89	Could not be modeled
GSM, adrenal medulla pheochromocytoma (benign and malignant)	Could not be modeled
GSM, pituitary gland adenoma	2.86	1.15	Could not be modeled
GSM, combined heart schwannoma, brain glioma, and meninges neoplasm, adrenal pheochromocytoma, and pituitary gland adenoma	Could not be modeled

^a Calculated BMD value is greater than the 6 W/kg highest exposure dose in the NTP study

ISSN: 1476-069X